A sequence of cellular and molecular events involved in IL 12-induced tumour regression
- 31 October 1995
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 146 (7-8), 638-644
- https://doi.org/10.1016/0923-2494(96)83042-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-γ production by anti-tumor T cellsInternational Immunology, 1995
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.The Journal of Experimental Medicine, 1993
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.The Journal of Experimental Medicine, 1991
- The cytokine networkImmunology Today, 1989
- Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.The Journal of Experimental Medicine, 1989
- Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.The Journal of Experimental Medicine, 1989
- Interferon: a cytotoxic T lymphocyte differentiation signalEuropean Journal of Immunology, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cellsNature, 1982